Solid Biosciences Inc. SLDB Return on invested capital

Return on invested capital at other companies

BiogenBIIB

4.6%-3.5pp

Neurocrine BiosciencesNBIX

17.5%+5.1pp

InsmedINSM

-126.1%-49.9pp

RegenxbioRGNX

-103.9%+612pp

Dyne Therapeutics, Inc.DYN

-188.2%+14.8pp

Edgewise Therapeutics, Inc.EWTX

-47.1%+14.7pp

FAQ

What is Solid Biosciences Inc.'s return on invested capital?

Solid Biosciences Inc. (SLDB) reported return on invested capital of -112.5% in Q2 2026.

How has Solid Biosciences Inc.'s return on invested capital changed year-over-year?

Solid Biosciences Inc.'s return on invested capital increased by 4.9% year-over-year, from -118.3% to -112.5%.

What is the long-term trend for Solid Biosciences Inc.'s return on invested capital?

Over 3 years (2022 to 2025), Solid Biosciences Inc.'s return on invested capital has grown at a 10.1% compound annual growth rate (CAGR), from -120.8% to -161.1%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.